nse,bse,nseindia,nse india,share price,stock price,stock value,shares prices,share prices,stock quote,stock prices, share prices, corporate announcements,board meetings,corporate actions,dividends,agm,stock split,bonus

Venus Remedies Limited (NSE India Code : VENUSREM) BUY

Company Name :

Enter Company Name or NSE Code

VENUSREM Technical Levels

Resistance 2		293.95
Resistance 1		287.25
PIVOT		283.10
Support 1		276.40
Support 2		265.55

VENUSREM Fundamentals

Earning Growth		1.68%
Profit Margin		13.52
PE		3.65
EPS		57.89
Quarter		30-Sep-11

VENUSREM Futures

Close
Contracts Traded
Open Interest(OI)
Change in OI
Lot Size

VENUSREM Options

Most Active Call
Most Active Put
Highest OI Call
Highest OI Put
Expiry Date

VENUSREM Technical Levels

Other Stocks from Pharmaceuticals Sector AARTIDRUGS ABBOTINDIA AJANTPHARM ALCHEM ALKALI ALPA AMRUTANJAN ANKURDRUGS ARL ASTRAZEN AUROPHARMA AVENTIS BALPHARMA BIOCON BLISSGVS CADILAHC CELESTIAL CIPLA DISHMAN DIVISLAB DRREDDY ELDERPHARM FDC FKONCO GLAXO GLENMARK GRANULES INDOCO INDSWFTLAB INDSWFTLTD IPCALAB JAGSNPHARM JBCHEPHARM JUBILANT KILITCH KOPRAN LUPIN LYKALABS MANGALAM MERCK MOREPENLAB NATCOPHARM NECLIFE NEULANDLAB OPTOCIRCUI ORCHIDCHEM PANACEABIO PARABDRUGS PFIZER PIRHEALTH

Sponsored Advertisement

VENUSREM Share Price on 5-10-2012

Open		280.5
High		282.45
Low		271.2
Close		275
Volume		28630
Change		-3.15 (-1.13%)

Series		EQ
Date of Listing		20-Dec-06
Paid Up Value		10
Face Value		10
Market Capital		0 Crores
52 Week High/Low		308.75 / 149

Sponsored Advertisement

Venus Remedies Limited Company Profile

Venus Remedies (VENRE) is a research and development driven pharmaceutical manufacturing company. It was incorporated as a private limited company on Sept. 15, 1989 and converted into a public limited company on Sept. 19, 1994. The range of products covers cephalosporins, carbapenems and oncology drugs, intravenous products, vials/lyophilized injectables, pre-filled syringes, hormones, ampules and biological products. These are manufactured in facilities certified as EU-GMP, WHO-GMP, ISO 9001, ISO 14001 & ISO18001, Ukrainian Columbian, Uganda, Zimbabwe, Syrian and European GMP compliant. The three manufacturing units are located in Germany and Panchkula and Baddi in India. The Baddi unit has a manufacturing capacity of 30 million vials Ciphelosporine p.a. and 10 million vials Oncologicals p.a. The company started its sixth and last phase of the Rs 1,500 million expansion project in January 2008 including the state-of-the-art hi-tech research facility Venus Medicine Research Center in Baddi with provision for eight dedicated plants manufacturing injectible formulations. Recently in March 2008, the company filed its 7th patent application with the Indian Patent Office for an antibiotic for the treatment of bacterial/multi-bacterial infections in children and was set to launch an innovative therapy for APE/cystis fibrosis patients after completion of the multi-centered phase II clinical trials. Marketing tie-ups are in place with Indian pharmaceutical companies like Ipca Laboratories, Elder Pharmaceuticals, and many others. The company has inked an agreement with Pharma Match R&D, based in Amsterdam, Netherlands for jointly preparing, registering and marketing an EU E-CTD Dossier for a latest generation Carbapenem injectable. Several patent cooperation treaty applications have been filed and a licensing agreement signed with the University of Illinois, USA for its patent technology for detection of tumors by imaging. The company exports directly to Nepal, Yemen, Ukraine and Sri Lanka. It has tie-ups with multinational concerns for indirect exports to CIS and other countries. The registered office is located at SCO 39, Sector 26, Madhya Marg, Chandigarh-160019.

VENUSREM Intraday Realtime Chart

VENUSREM Corporate Announcements

DATE	PURPOSE
06-Aug-12	Financial Result Updates
26-Jul-12	Updates
10-Jul-12	Updates
21-Jun-12	Dividend
21-Jun-12	Financial Result Updates

VENUSREM Corporate Actions

DATE	PURPOSE
20-Sep-12	AGM/DIVD RS. 3/- PR SHRE
22-Sep-11	Annual General Meeting And Dividend Rs.3/- Per Share
22-Sep-11	AGM/DIV-RS.3/- PER SHARE

VENUSREM Board Meetings

MEETING DATE	PURPOSE
04-Aug-12	Results/Others
21-Jun-12	Results/Dividend
04-May-12	Results/Others
27-Feb-12	Issue of Securities
27-Jan-12	Results/Others

VENUSREM Related companies

Symbol	Company Name
AARTIDRUGS	Aarti Drugs Limited
ABBOTINDIA	Abbott India Limited
AJANTPHARM	Ajanta Pharma Limited
ALCHEM	Alchemist Limited
ALKALI	Alkali Metals Limited

Most Active NSE INDIA Stocks

HDFC LITL IVRCLINFRA HDIL UNITECH JPASSOCIAT GVKPIL TATAMOTORS IFCI IBREALEST ESSAROIL GMRINFRA BIRLAPOWER HINDALCO BHEL RENUKA RCOM DLF SUZLON RELCAPITAL IDFC ADANIENT ITC TATAPOWER BALLARPUR

Free Stock Market Tips:

What is the structure of Derivative Markets in India?

Home	Stock Market	IPO	Mutual Funds	Education	Paid Service
About us	Share Market	IPO Watch	MF News	IPO	Subscription
VJonDalalStreet	Technical Analysis	New IPO Review	Old Funds	Articles	Equity Performance
DalalStreet Blog	Stock Market News	Indian IPO News	New Funds	Stock Market	Futures Performance
Free Sms Alerts	World Stock Market	IPO Allotment Status	Best Funds	Financial Terms	Options Performance
Privacy	Stock Recommendations	Grey Market Premium	MF Analysis	Futures & Options	Jackpot Performance

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither VJonDalalStreet.com website nor any of its promoters shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes acceptance of our Disclaimer